Liver cancer study tracks Real-World treatments and survival
NCT ID NCT07449637
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study watches 200 adults with intermediate-stage liver cancer to see which treatments doctors actually use and how long patients survive. It does not test a new drug or procedure. The goal is to learn from real-world care to help guide future treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BCLC STAGE B HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sohag Oncology Center
Sohag, Sohag Governorate, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive beads offer new hope for inoperable liver cancer
- AI scans 3000 liver cancer patients to pick best therapy
- Immunotherapy duo after radiation shows promise for untreatable liver cancer
- Liver cancer drug combo shows promise but study halted early
- New drug combo shows promise for Tough-to-Treat liver cancer